Expression of rat CD59: Functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function

Immunology

Volumn 90, Issue 4, 1997, Pages 640-646

  Rushmere, N K ^a   Tomlinson, S ^b   Morgan, B P ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CD59 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; COMPLEMENT INHIBITION; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; MUTAGENESIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT;

EID: 0030999225     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00200.x     Document Type: Article

References (38)

1. MORGAN B.P. & MERI S. (1994) Membrane proteins that protect against complement lysis. Springer Semin Immunopathol 15, 369.
2. MORGAN B.P. (1995) Physiology and pathophysiology of complement: progress and trends. Crit Rev Clin Lab Sci 32, 265.
3. DAVIES A., SIMMONS D.L., HALE G. et al. (1989) CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 170, 637.
4. DAVIES A. & LACHMANN P.J. (1993) Membrane defence against complement lysis: The structure and biological properties of CD59. Immunol Res 12, 258.
5. MERI S., MORGAN B.P., DAVIES A. et al. (1990) Human protectin (CD59), an 18000-20000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71, 1.
6. ROLLINS S.A., ZHAO J., NINOMIYA H. & SIMS P.J. (1991) Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J Immunol 146, 2345.
7. OKADA N., HARADA R., FUJITA T. & OKADA H. (1989) A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement. Int Immunol 1, 205.
8. OKADA N., HARADA R., FUJITA T. & OKADA H. (1989) Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement. J Immunol 143, 2262.
9. TAKIZAWA H., TAKAHASHI K., MURAKAMI T., OKADA N. & OKADA H (1992) Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection. Eur J Immunol 22, 1943.
10. HUGHES T.R., PIDDLESDEN S.J., WILLIAMS J.D., HARRISON R.A. & MORGAN B.P. (1992) Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement. Biochem J 284, 169.
11. VAN DEN BERG C.W., HARRISON R.A. & MORGAN B.P. (1993) The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity. Immunology 78, 349.
12. VAN DEN BERG C.W., HARRISON R.A. & MORGAN B.P. (1995) A rapid method for the isolation of analogues of human CD59 by preparative SDS-PAGE: application to pig CD59. J Immunol Methods 179, 223.
13. VAN DEN BERG C.W. & MORGAN B.P. (1994) Complement-inhibiting activities of human CD59 and analogues of from rat, sheep, and pig are not homologously restricted. J Immunol 152, 4095.
14. NINOMIYA H., STEWART B.H., ROLLINS S.A., ZHAO J., BOTHWELL A.L.M. & SIMS P.J. (1992) Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity. J Biol Chem 267, 8404.
15. DONG S., GILBERT A., NUSSENZVEIG D. & TOMLINSON S. (1995) Defining the regions of CD59 important for binding and function. Ninth International Congress of Immunology, San Fransisco, CA, USA. Abs 606.
16. RUSHMERE N.K., HARRISON R.A., VAN DEN BERG C.W. & MORGAN B.P. (1994) Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site. Biochem J 304, 595.
17. WALSH L.A., TONE M. & WALDMANN H. (1991) Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement. Eur J Immunol 21, 847.
18. ZHAO J., ROLLINS S.A., MAHER S.E., BOTHWELL A.L.M. & SIMS P.J. (1991) Amplified gene expression in CD59-transfected chinese hamster ovary cells confers protection against the membrane attack complex of human complement. J Biol Chem 266, 13418.
19. DAVIES A. & MORGAN B.P. (1993) Expression of the glycosylphosphatidylinositol-linked complement-inhibiting protein CD59 antigen in insect cells using a baculovirus vector. Biochem J 295, 889.
20. NAKANO Y., TOZAKI T., KIKUTA K. et al. (1995) Determination of the active sites of CD59 with synthetic peptides. Mol Immunol 32, 241.
21. MANIATIS T., FRITSCH E.F. & SANDBROOK J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, New York.
22. ABRAHA A., MORGAN B.P. & LUZIO J.P. (1988) The preparation and characterisation of monoclonal antibodies to human complement component C8. Biochem J, 251, 285.
23. ROTHER R.P., ROLLINS S.A., MENNONE J. et al. (1994) Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B cells confers resistance to human complement. Blood 84, 2604.
24. CHARREAU B., CASSARD A., TESSON L. et al. (1995) Permanent expression of human CD59 and/or decay accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis. Transplant Proc 27, 336.
25. AKAMI T., ARAKAWA K., OKAMOTO M. et al. (1994) Enhancement of the complement regulatory function of CD59 by site-directed mutagenesis at the N-glycosylation site. Transplant Proc 26, 1256.
26. ROGERS C.A., GASQUE P., PIDDLESDEN S.J., OKADA N., HOLERS V.M. & MORGAN B.P. (1996) Expression and function of membrane regulators of complement on rat astrocytes in culture. Immunology 88, 153.
27. HUSLER T., LOCKERT D.H., KAUFMAN K.M., SODETZ J.M. & SIMS P.J. (1995) Chimeras of human complement C9 reveal the site recognized by complement regulatory protein CD59. J Biol Chem 270, 3483.
28. LOCKERT D.H., KAUFMAN K.M., CHANG, C.-P., HUSLER T., SODETZ J.M. & SIMS P.J. (1995) Identity of the segment of human complement C8 recognized by complement regulatory protein CD59. J Biol Chem 270, 19723.
29. CHANG, C.-P., HUSLER T., ZHAO J., WIEDMER T. & SIMS P.J. (1994) Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59. J Biol Chem 269, 26424.
30. HUSLER T., LOCKERT D.H. & SIMS P.J. (1996) Role of a disulfide-bonded peptide loop within human compement C9 in the species-selectivity of complement inhibitor CD59. Biochemistry 35, 3263.
31. MERI S., LEHTO T., SUTTON C.W., TYYNELA J. & BAUMANN M. (1996) Strucural composition and functional characterisation of soluble CD59: heterogeneneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis. Biochem J 316, 923.
32. FLETCHER C.M., HARRISON R.A., LACHMANN P.J. & NEUHAUS D. (1994) Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. Structure 2, 185.
33. KIEFFER B., DRISCOLL P.C., CAMPBELL I.D., WILLIS A.C., VAN DER MERWE A.P. & DAVIS S.J. (1994) Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell surface protein domain related to snake venom neurotoxins. Biochemistry 33, 4471.
34. DECKERT M., KUBAR J., ZOCCOLA D. et al. (1992) CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. J Immunol 148, 672.
35. HAHN W.C., MENU E., BOTHWELL A.L.M., SIMS P.J. & BIERER B.E. (1992) Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256, 1805.
36. VAN DER MERWE P.A., BARCLAY A.N., MASON D.W. et al. (1994) Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33, 10149.
37. MENU E., TSAI B.C., BOTHWELL A.L.M., SIMS P.J. & BIERER B.E. (1994) CD59 Costimulation of T cell activation; CD58 Dependence and requirement for glycosylation. J. Immunol 153, 2444.
38. ROSSE W.F. (1990) Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemaglobinuria. Blood 75, 1595.